Developed by Cellegy Pharmaceuticals now being made by ProStrakan

[Guest guest]

Tostrex (2% testosterone gel) is [marketed in] Sweden. Tostrex gel is a

transdermal

testosterone replacement therapy for use in hypogonadal men.

Prostrakan is the company marketing/distributing this new gel, and it sounds

like this gel

was first marketed in Sweeden.

" Tostran (testosterone gel for hypogonadal males) (branded Tostrex in Sweden) o

Following launch in Sweden, has now achieved 29% market share of

testosterone

gels o EU Mutual Recognition Procedure (MRP) was successfully concluded

in April

to allow pan-EU launches in 2007 o Product rights extended to include Russia

and CIS o

Post-marketing, Phase IIIb/IV study progressing to plan o Product to be

branded as

Tostran for most EU markets "

" Tostran (testosterone gel for androgen deficient males) – reported sales of

£0.1m in the

Swedish market in the period (£Nil) following its launch in September 2005

(where it is

branded Tostrex) and it is notable that it now has attained a 29% market share

of the

testosterone gels market. The product completed the EU MRP in April 2006 and we

are

now in the process of receiving national licences across other EU countries

which in turn

will permit the launch of Tostran from early next year. During the

period the

geographical rights to Tostran were extended to include Russia and

CIS. We also

continue on schedule with a Phase IIIb / IV trial (TIMES 2 trial)

into the impact of

testosterone replacement therapy in male Type 2 Diabetes patients and

those with

Metabolic Syndrome. "

" Cellegy Pharmaceuticals, Inc. announced today that it has entered into an

agreement with

Strakan International Limited, a wholly owned subsidiary of ProStrakan Group

plc, a

publicly-traded company based in the United Kingdom, under which ProStrakan will

acquire Cellegy's rights to Cellegesic (nitroglycerin ointment), which is

branded Rectogesic

outside of the United States, Fortigel (testosterone gel), Tostrex (testosterone

gel), and

Tostrelle (testosterone gel), and related intellectual property assets.

ProStrakan currently is

Cellegy's marketing partner for Rectogesic and Tostrex in the European Union

markets

pursuant to exclusive distribution agreements "